Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close Other

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02317380
Recruitment Status : Completed
First Posted : December 16, 2014
Last Update Posted : September 20, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

Tracking Information
First Submitted Date December 13, 2014
First Posted Date December 16, 2014
Last Update Posted Date September 20, 2018
Study Start Date December 13, 2014
Actual Primary Completion Date November 10, 2015   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: December 13, 2014)
Intentions to lose weight/ talk to doctor [ Time Frame: Immediately post-experiment ]
Original Primary Outcome Measures Same as current
Change History Complete list of historical versions of study NCT02317380 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close Other
Official Title Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close Other
Brief Summary

Background:

- Researchers want to learn about people s beliefs and values. They also want to learn about how people respond to information about cancer risk. They have created two short studies. They have combined these studies for convenience.

Objective:

- To learn about people s beliefs and values, and about how people respond to information about cancer risk.

Eligibility:

- Adults age 40-70 who are overweight, have never had cancer, and have an opposite-sex close relationship with someone in that age group who is also overweight.

Design:

  • This study will take place online or in a laboratory.
  • Participants will take part in two studies. One is Values Study. The other is Cancer Risk Information.
  • In Values Study, some participants will choose the most important value from a list. They will write about why that value is important to them. Others will choose the least important value from a list. They will write about why that value may be important to someone else.
  • In Cancer Risk Information, participants will read a health message about a cancer risk relevant to themselves or to a close other. Some will wear special glasses that track their eye movements as they read.
  • Participants will then answer questions about their beliefs about cancer risk and their intentions to lose weight.
  • Both studies will take 30 minutes.
Detailed Description Self-affirmation, a process by which individuals reflect on cherished personal values is a potent means of augmenting the effectiveness of threatening health communications. Individuals tend to be defensive against information suggesting their behavior puts them at risk for disease or negative health. Previous evidence suggests that self-affirmation may reduce defensiveness to threatening health information, increasing openness to the message and resulting in increased disease risk perceptions, disease-related worry, intentions to engage in preventive behavior, and actual behavioral change. One mechanism by which self-affirmation may be effective is by reducing self-focus and expanding self-concept. If this is the case, self-affirmation may not be effective in reducing defensiveness against information that is threatening to one s close other. We are proposing two studies to examine whether self-affirmation is equally effective at reducing defensiveness against threatening information for the self and for a close other. These studies will not only highlight conditions under which self-affirmation is effective, but also shed light on mechanisms underlying the effect.
Study Type Observational
Study Design Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Not Provided
Study Population Not Provided
Condition
  • Ego
  • Social Science
  • Cancer Prevention
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: April 4, 2018)
1019
Original Estimated Enrollment
 (submitted: December 13, 2014)
700
Actual Study Completion Date September 18, 2018
Actual Primary Completion Date November 10, 2015   (Final data collection date for primary outcome measure)
Eligibility Criteria
  • INCLUSION CRITERIA

For Study 1

-Knowledge Networks panel members will be eligible if they are aged 40-70, overweight, and

have never been diagnosed with cancer (to ensure relevance to breast and prostate cancer risk, the topic of

the health message). Individuals will also be screened for inclusion based on whether they report having

an opposite-sex close relationship with another adult age 40-70 who is also overweight (e.g., opposite-sex

spouse, close friend, or family member).

For Study 2

-Community individuals will be subject to the same inclusion criteria.

Sex/Gender
Sexes Eligible for Study: All
Ages 40 Years to 70 Years   (Adult, Older Adult)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT02317380
Other Study ID Numbers 999915034
15-C-N034
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
Study Sponsor National Cancer Institute (NCI)
Collaborators Not Provided
Investigators
Principal Investigator: Rebecca A Ferrer, Ph.D. National Cancer Institute (NCI)
PRS Account National Institutes of Health Clinical Center (CC)
Verification Date September 18, 2018